Triplet Therapeutics, Inc., a biotechnology company leveraging insights from the human genetics of repeat expansion disorders, announced that Nessan Bermingham, Ph.D., Triplet’s chief executive officer, president and founder, will present at the following upcoming virtual events:
March 25, 2021
· 2 min read